Tokyo, Japan

Tomoko Hirama



 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2016-2020

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Tomoko Hirama: Innovator in Protein Engineering

Introduction

Tomoko Hirama is a notable inventor based in Tokyo, Japan. She has made significant contributions to the field of protein engineering, particularly in the development of methods for screening protein candidates. With a total of two patents to her name, her work has the potential to impact various industries, including therapeutics.

Latest Patents

Hirama's latest patents focus on the screening of protein candidates. The successful application of engineered proteins as therapeutics or in other industries requires these proteins to exhibit good expression levels, favorable biophysical properties, and desired affinities to their targets. Her invention provides a method for screening large numbers of protein candidates (PCs) across all three aspects simultaneously. In this method, PCs are fused to a protein anchor, which is then captured by the target or antigen. The captured PCs are evaluated for their expression levels, biophysical properties, and affinities using conventional methods.

Career Highlights

Tomoko Hirama is currently affiliated with the National Research Council of Canada, where she continues her research and development in protein engineering. Her innovative approaches have garnered attention in the scientific community, contributing to advancements in the field.

Collaborations

Hirama collaborates with Jianbing Zhang, a fellow researcher who brings valuable insights and expertise to their joint projects. Their partnership enhances the research outcomes and fosters a collaborative environment for innovation.

Conclusion

Tomoko Hirama's work in protein engineering exemplifies the importance of innovation in scientific research. Her patents and collaborations highlight her commitment to advancing the field and improving therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…